.svg)
.png)
Customer Testimonial
GSK’s approach to microsegmentation
GSK uses Elisity’s identity-based microsegmentation to secure pharmaceutical manufacturing networks. In this customer video, Mike Elmore discusses the move from traditional firewall segmentation to device visibility and policies that follow identity.
Watch the 3-minute, 53-second story · Video published September 2023
GSK Spotlight
“I can sleep much better at night knowing that I have a solution and I can actually get the visibility.”
— Mike Elmore, identified as GSK CISO in the 2023 video
GSK worked with Elisity on the segmentation approach described in this customer story.
Why did GSK choose identity-based microsegmentation?
Protecting pharmaceutical production means understanding which devices are on the network and how they communicate. In this video, Mike Elmore describes GSK’s work with Elisity to move beyond a traditional firewall segmentation project.
Visibility before policy
Elmore describes identifying devices and the identities behind them so security teams can make informed access decisions.
Policy that follows the device
Rather than tying access only to where a device connects, GSK’s approach uses identity context to keep policy with the device as it moves.
A manufacturing security perspective
The conversation connects network security with the responsibility of protecting medicine production.
Explore the Elisity microsegmentation platform or microsegmentation for manufacturing and industrial networks.
Page updated .
GSK microsegmentation case study: questions and answers
A quick guide to the customer video and the approach it describes.
What does the GSK customer video cover?
Mike Elmore discusses GSK’s pharmaceutical manufacturing security challenges, its work with Elisity, device visibility and identity-based microsegmentation.
How does identity context change network policy?
In GSK’s account, devices are profiled along with their identity context, allowing policy to follow a device wherever it connects to the network.
When was the GSK video published?
The video was published in September 2023. Mike Elmore is identified as GSK CISO in the recording; the story describes GSK’s experience at that time.
Schedule a Demo
Plan your microsegmentation evaluation
Dive deeper into the critical need for microsegmentation, evaluation criteria, key features, implementation considerations, and how to build a business case. This guide provides the insights you need to make an informed decision.
- Understand the evolution from perimeter defense to Zero Trust.
- Discover key success factors for selecting a microsegmentation vendor.
- Learn how to navigate deployment and integration.